Organometallics
Article
9,9′-Bis-4,5-diaza-9H-fluorene. The ligand was prepared as
described in the literature.10−12 Stirring 4,5-diazafluorenone for 4 h
at 100 °C in the presence of hydrazine hydrate gave 9,9′-bis-4,5-diaza-
9H-fluorene in 45% yield. The two products (i.e., 4,5-diazafluorene
and 9,9′-bis-4,5-diaza-9H-fluorene) were separated on a silica gel
column (50% ethyl acetate, 50% hexane). 9,9′-Bis-4,5-diaza-9H-
fluorene did not sublime but was ground into a fine powder and
heated at 110 °C under reduced pressure for 1 week in order to
This ligand may be viewed as a cyclopentadiene that shares
edges with two pyridine ligands at the 1,2- and 3,4-positions.
Thus, the NCCN torsion angle is fixed to be close to 0° and
one of the two CH2 hydrogens is acidic; the pKa of CpH is 18,
and that of fluorene is 22.6.6 The experimental and computa-
tional studies show that the ground state is multiconfigura-
tional. The experimental studies also show that the adduct
eliminates dihydrogen stoichiometrically. Combining these
experimental and theoretical results allows for a molecular
level of understanding of the origin of the reactivity of
Cp*2Yb(4,5-diazafluorene).
1
eliminate the water of hydration. H NMR (CDCl3, 300 K): δ (ppm)
8.68 (d, 4H, J = 4.8 Hz), 7.31 (d, 4H, J = 8.0 Hz), 7.13 (dd, 4H, J = 7.8
Hz), 4.88 (s, 2H, −CH). The deuterated 9,9′-bis-4,5-diaza-9D-
fluorene was prepared in a similar way using ND2ND2·D2O (% H
1
∼5%). H NMR (CDCl3, 300 K): δ (ppm) 8.68 (d, 4H, J = 4.8 Hz),
7.31 (d, 4H, J = 8.0 Hz), 7.13 (dd, J = 7.8 Hz), 4.88 (s, 0.009H, −CH).
2D NMR (CDCl3, 300 K): δ 4.92 (s, CD2).
EXPERIMENTAL SECTION
■
Synthesis of Complexes. Cp*2Yb(4,5-diazafluorene) (1). A cold
toluene solution (10 mL) of Cp*2Yb(OEt2) (0.127 g, 0.245 mmol)
was added dropwise to a cold suspension of 4,5-diazafluorene (0.042 g,
0.245 mmol) in toluene (5 mL) at 0 °C. The brown-purple suspension
was stirred for 2 h and then filtered at 0 °C. The filtrate was cooled at
−20 °C, and a dark brown microcrystalline powder formed overnight
(16 h). The powder was collected by filtration (101 mg, 80%), washed
three times with cold toluene, and dried under reduced pressure (67
General Considerations. All reactions were performed using
standard Schlenk-line techniques or in a drybox (MBraun). All
glassware was dried at 150 °C for at least 12 h prior to use. Toluene
and pentane were dried over sodium and distilled, while CH2Cl2 was
purified by passage through a column of activated alumina. Toluene-d8,
pyridine-d5, and C6D6 were dried over sodium. All solvents were
degassed prior to use. Infrared samples were prepared as Nujol mulls
and taken between KBr plates and recorded on a Thermo Scientific
Nicolet IS10 spectrometer. Samples for ultraviolet, visible, and near-
infrared spectrometry were prepared in a Schlenk-adapted quartz
cuvette, and spectra were obtained using a Varian Cary 50 scanning
spectrophotometer. Melting points were determined in sealed
capillaries prepared under nitrogen and are uncorrected. Elemental
analyses and mass spectra (EI) were determined by the Micro-
analytical Laboratory of the College of Chemistry, University of
California, Berkeley, CA. X-ray structural determinations were
performed at CHEXRAY, University of California, Berkeley, CA.
Magnetic susceptibility measurements were made for all samples at 5
and 40 kOe in a 7 T Quantum Design Magnetic Properties
Measurement System, which utilized a superconducting quantum
interference device (SQUID). Sample containment and other
experimental details have been described previously.4 The samples
were prepared for X-ray absorption experiments as described
previously, and the same methods were used to protect the air-
sensitive compounds from oxygen and water.7 X-ray absorption
measurements were made at the Stanford Synchrotron Radiation
Lightsource on beamline 11-2. The samples were prepared and loaded
into a liquid helium-flow cryostat at the beamline as described
previously.7 Data were collected at temperatures ranging from 30 to
300 K, using a Si(220) double-crystal monochromator. Fit methods
were the same as those described previously.7
1
mg, 53%). H NMR (toluene-d8, 300 K): δ (ppm) 71.07 (2H), 30.50
1
(2H), 6.35 (2H), 4.65 (2H), 4.23 (30H, Cp*). H NMR (thf-d8, 297
K): δ (ppm) 45.59 (2H), 27.61 (2H), 9.51 (2H), 8.81 (2H), 3.05
1
(30H, Cp*). H NMR (py-d5, 297 K): δ (ppm) 35.80 (2H), 23.41
(2H), 9.35 (2H), 6.34 (2H), 2.94 (30H, Cp*). Mp: 273−275 °C.
Anal. Calcd for C31H38N2Yb: C, 60.87; H, 6.26; N, 4.58. Found: C,
60.63; H, 6.46; N, 4.45. Vis−near-IR (toluene; λ, nm (ε, cm−1 M−1)):
474 (2840), 501 (3410), 789 (1680), 909 (2450), 1005 (1390). IR
(cm−1): 2962 (w), 2903 (w), 2850 (m), 1595 (w), 1578 (w), 1563
(m), 1435 (m), 1406 (s), 1378 (m), 1296 (s), 1260 (m), 1232 (m),
1164 (m), 1089 (s), 1015 (s), 924 (w), 859 (m), 796 (m), 776 (m),
765 (s), 729 (s), 695 (w). MS: {Cp*2Yb(4,5-diazafluorene) − H} m/z
611.
Cp*2Yb(4,5-diazafluorene-d2) (1-d2). The synthesis was similar to
that used for the unlabeled compound using 145 mg (0.280 mmol) of
1
Cp*2Yb(OEt)2. H NMR (Toluene-d8, 300 K): δ (ppm) 71.07 (2H),
2
30.50 (2H), 6.35 (2H), 4.65 (0.16H, −CH2), 4.23 (30H, Cp*). H
NMR (C6D6, 298 K): δ 4.82. Mp: 273−275 °C. Anal. Calcd for
C31H36D2N2Yb: C, 60.67; H, 5.95; N, 4.59. Found: C, 59.56; H, 6.07;
N, 4.31. Vis−near-IR (toluene, λ, nm (ε, cm−1 M−1)): 474 (2840), 501
(3410), 789 (1680), 909 (2450), 1005 (1390). IR (cm−1): 2183 (m),
2117 (w), 1580 (m), 1538 (m), 1459 (m), 1396 (s), 1378 (m), 1292
(s), 1260 (m), 1246 (m), 1163 (s), 1095 (s), 1015 (s), 934 (w), 799
(m), 757 (m), 731 (s). MS: {Cp*2Yb(4,5-diazafluorene-d2) − D} m/z
612.
Kinetics Experiments and NMR Experiments. 1H NMR spectra
were recorded on Bruker AVB-400 MHz, DRX-500 MHz, AV-600
1
MHz, and Advance 300 MHz spectrometers. H chemical shifts are
Cp*2Yb(4,5-diazafluorenyl) (2). The complex Cp*2Yb(OEt2)
(0.127 g, 0.245 mmol) was mixed with 4,5-diazafluorene (0.042 g,
0.245 mmol), and toluene (10 mL) was added at room temperature.
The brown-purple suspension was stirred for 48 h at 70 °C, cooled to
room temperature, and filtered. The volume of the filtrate was reduced
to 2 mL, and the deep purple solution was cooled at −20 °C. The
small dark purple crystals that formed were collected by filtration and
given relative to δ 0 (TMS). Kinetics studies were performed using a
1
Bruker DRX-500 MHz H NMR at a given temperature ( 0.1 °C)
and by integrating data manually for each spectrum. All the data were
integrated relative to an internal reference (toluene, dihydroanthra-
cene, or the grease peak) to track mass loss during the progress of the
reaction. The measured loss of intensity did not exceed 5% over the
kinetic study.
1
dried under reduced pressure (77 mg, 52%). H NMR (toluene-d8,
Synthesis of Ligands. 4,5-Diazafluorene. The ligand 4,5-
diazafluorene was prepared according to a published procedure by
reducing 4,5-diazafluorenone by an excess of hydrated hydrazine
(NH2NH2·H2O; 16 h at 100 °C).8,9 After extraction in CH2Cl2, the
pure 4,5-diazafluorene was sublimed at 80 °C under reduced pressure.
1H NMR (CDCl3, 300 K): δ (ppm) 8.78 (d, 2H, J = 7.8 Hz, H3,6 or
H1,8), 7.94 (d, 2H, J = 7.6 Hz, H1,8 or H3,6), 7.35 (dd, J = 8.0 Hz, H2,7),
3.92 (s, 2H, −CH2). Mp: 172 °C dec (lit.8 mp 172 °C). Deuterated
4,5-diazafluorene-9,9-d2 was prepared in a similar way using
ND2ND2·D2O (% H ∼5%). 1H NMR (CDCl3, 300 K): δ (ppm)
8.79 (d, 2H, J = 7.6 Hz, H3,6 or H1,8), 7.92 (d, 2H, J = 8.0 Hz, H1,8 or
H3,6), 7.34 (2H, dd, J = 7.8 Hz, H2,7), 3.92 (s, 0.08H, −CHD), 3.90 (s,
0.04H, −CH2); 94% of the CH2 group is deuterated. 2D NMR
(CDCl3, 300 K): δ 3.92 (s, CD2).
300 K): δ (ppm) 122.19 (2H), 31.54 (2H), 16.78 (2H), 11.83 (1H),
3.69 (30H, Cp*) H NMR (thf-d8, 297 K): δ (ppm) 123.51 (2H),
1
31.94 (2H), 16.85 (2H), 11.57 (1H), 3.66 (30H, Cp*). 1H NMR (py-
d5, 297 K): δ (ppm) 124.38 (2H), 32.32 (2H), 17.16 (2H), 12.02
(1H), 3.98 (30H, Cp*). Mp: 275−278 °C dec. Anal. Calcd for
C31H37N2Yb: C, 60.97; H, 6.11; N, 4.59. Found: C, 61.04; H, 5.94; N,
4.48. Vis−near-IR (λ, nm (ε, cm−1 M−1)): 426 (1250), 502 (360), 538
(405), 581 (395), 634 (210), 963 (40), 908 (30), 1001 (55). IR
(cm−1): 2954 (w), 2924 (w), 2854 (m), 2725 (m), 1561 (w), 1528
(w), 1460 (s), 1408 (w), 1377 (s), 1327 (w), 1300 (m), 1261 (m),
1260 (m), 1164 (w), 1090 (s), 1020 (s), 947 (w), 888 (w), 798 (s),
781 (m), 726 (m), 684 (m).
Cp*2Yb(4,5-diazafluorenyl-d) (2-d). The synthesis was similar to
that used for the unlabeled complex from 51 mg (0.099 mmol) of
1151
dx.doi.org/10.1021/om300876b | Organometallics 2013, 32, 1150−1158